ADXN — Addex Therapeutics Share News
0.000.00%
- CH₣5.17m
- CH₣3.56m
- CH₣0.17m
Swiss stocks - Factors to watch on November 11
Brief: Addex Therapeutics Q2 Net Income at CHF 12.9 Million
Swiss stocks - Factors to watch on June 6
Swiss stocks - Factors to watch on April 18
Brief: Addex Therapeutics Q3 Operating Loss at CHF 2.7 million
Brief: Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment Of Patients
Brief: Addex Announces Plan To Implement ADS Ratio Change
Brief: Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Addex rises on positive data from Parkinson's drug study in animals
Brief: Addex Reports Q3 Loss Per Share CHF 0.09
Brief: Addex Therapeutics Issued 32.6 Million New Registered Shares At A Nominal Value Of CHF 0.01 Each To Addex Pharma SA
Brief: Addex Therapeutics Files Prospectus Related To Resale Of Up To 4.25 Million ADS
Swiss stocks - Factors to watch on July 27
Brief: Addex Completes $4.2 Million Equity Financing
Addex falls after $4.2 mln equity raise from healthcare fund
Addex plunges as it ends Parkinson's disease drug study, suspends guidance
Brief: Addex Ends Dipraglurant Phase 2B/3 Study Due To Slow Recruitment Rate
Swiss stocks - Factors to watch on June 17
NASDAQ RESUMED AT 02:30 PM